Literature DB >> 23506583

Retrograde approach for the recanalization of coronary chronic total occlusion: collateral selection and collateral related complication.

Jian-Ying Ma1, Ju-Ying Qian, Lei Ge, Bing Fan, Qi-Bing Wang, Yan Yan, Feng Zhang, Kang Yao, Dong Huang, Jun-Bo Ge.   

Abstract

BACKGROUND: The retrograde approach through collaterals has been applied in the treatment of chronic total occlusion (CTO) lesions during percutaneous recanalization of coronary arteries. This study was to investigate the success rate of recanalization and collateral related complications in patients when using the retrograde approach.
METHODS: Eighty-four cases subjected to retrograde approach identified from July 2005 to July 2012 were included in this study. Patient characteristics, procedural outcomes and in-hospital clinical events were evaluated.
RESULTS: Mean age of the patient was (59.6 ± 11.2) years old and 91.7% were men. The target CTO lesions were distributed among the left anterior descending artery in 45 cases (53.5%), left circumflex artery in one case (1.2%), right coronary artery in 34 cases (40.5%), and left main in four cases (4.8%). The overall success rate of recanalization was 79.8%. The septal collateral was three times more frequently used for retrograde access than the epicardial collateral, 68/84 (81%) vs. 16/84 (19%). Successful wire passage through the collateral channel was achieved in 58 (72.6%) patients. The success rate of recanalization was 93.1% (54/58) in patients with and 50% (13/26) in patients without successful retrograde wire passage of the collateral channel (P < 0.01). Successful retrograde wire passage through the collaterals was achieved in 49 of 68 septal collaterals (72.1%) and in 9 of 16 epicardial collaterals (56.3%) (P = NS). There was no significant difference between the septal collateral group and the epicardial group in the success rate of recanalization after retrograde wire crossing the collaterals (91.8% vs. 100%, P > 0.05). CART or reverse CART technique was used in 15 patients, and 14 patients (93.3%) were recanalized successfully. Collateral related perforation occurred in three (18.8%) cases with the epicardial collateral as the first choice (compared with the septal collateral group (0), P < 0.01). There were 17 (20.2%) patients failure of recanalize the CTO lesions, among which 13 (15.5%) were due to the failure of retrograde wire crossing the collaterals.
CONCLUSIONS: The retrograde approach is an effective technique to recanalize CTO lesions, the septal collateral was preferable. When the epicardial collateral is selected, careful manipulation of devices and wires is essential due to the potential risk of perforation of collateral channels.

Entities:  

Mesh:

Year:  2013        PMID: 23506583

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  4 in total

1.  Successful occluding by absorbable sutures for epicardial collateral branch perforation.

Authors:  Li Sheng; Yong-Tai Gong; Dang-Hui Sun; Yue Li
Journal:  J Geriatr Cardiol       Date:  2018-10       Impact factor: 3.327

Review 2.  Overview of Contemporary Chronic Total Occlusion Percutaneous Coronary Intervention Techniques: A Narrative Systematic Review.

Authors:  Talal Aljabbary; Andriy Katyukha; Gabby Elbaz-Greener; Kassandra Gressmann; Akshay Bagai; John J Graham; Ram Vijayaraghavan; Sanjog Kalra; Minh Vo; Harindra C Wijeysundera
Journal:  CJC Open       Date:  2021-06-06

3.  Incidence and characteristics of ventricular tachycardia in patients after percutaneous coronary revascularization of chronic total occlusions.

Authors:  Sebastian König; Enno Boudriot; Arash Arya; Julia-Anna Lurz; Marcus Sandri; Sandra Erbs; Holger Thiele; Gerhard Hindricks; Borislav Dinov
Journal:  PLoS One       Date:  2019-11-22       Impact factor: 3.240

4.  Reattempt Percutaneous Coronary Intervention of Chronic Total Occlusions after Prior Failures: A Single-Center Analysis of Strategies and Outcomes.

Authors:  Mingqiang Fu; Shufu Chang; Lei Ge; Dong Huang; Kang Yao; Feng Zhang; Qing Qin; Jianying Ma; Juying Qian; Junbo Ge
Journal:  J Interv Cardiol       Date:  2021-04-20       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.